Credit Suisse resumed coverage on Centogene with a new price target
$CNTG
Medical Specialities
Health Care
Credit Suisse resumed coverage of Centogene with a rating of Outperform and set a new price target of $14.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/5/2021 | $14.00 | Outperform | Credit Suisse |